IDXX vs NTRA
Idexx Laboratories and Natera, Inc., both Healthcare
Idexx Laboratories is the larger company at $44B against $33B. Over the past year NTRA returned +140% against -11% for IDXX. Ryufin's sector-relative Smart Score puts NTRA ahead, 10/10 against 9/10.
| Figure | IDXX | NTRA |
|---|---|---|
| Last close | $553 | $339 |
| Market cap | $44B | $33B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 38.9 | n/a |
| 1-year return | -11% | +140% |
| 5-year return | -18% | +201% |
| Ryufin Smart Scoresector-relative, 1–10 | 9/10 | 10/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Idexx Laboratories
Revenue of $1.2B in Q2 2026, net income $338M. Its largest reported line is Vet Lab Consumables, 36% of the disclosed total.
Natera, Inc.
Revenue of $753M in Q2 2026, net income null. Its largest reported line is US, 98% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.